SG11201604227XA - Articular cartilage imaging composition - Google Patents
Articular cartilage imaging compositionInfo
- Publication number
- SG11201604227XA SG11201604227XA SG11201604227XA SG11201604227XA SG11201604227XA SG 11201604227X A SG11201604227X A SG 11201604227XA SG 11201604227X A SG11201604227X A SG 11201604227XA SG 11201604227X A SG11201604227X A SG 11201604227XA SG 11201604227X A SG11201604227X A SG 11201604227XA
- Authority
- SG
- Singapore
- Prior art keywords
- articular cartilage
- imaging composition
- cartilage imaging
- composition
- articular
- Prior art date
Links
- 210000001188 articular cartilage Anatomy 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013257892 | 2013-12-13 | ||
| PCT/JP2014/082441 WO2015087839A1 (fr) | 2013-12-13 | 2014-12-08 | Composition pour imagerie de cartilage articulaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201604227XA true SG11201604227XA (en) | 2016-07-28 |
Family
ID=53371144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201604227XA SG11201604227XA (en) | 2013-12-13 | 2014-12-08 | Articular cartilage imaging composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10143762B2 (fr) |
| EP (1) | EP3081234B1 (fr) |
| JP (1) | JP6220894B2 (fr) |
| KR (1) | KR101860117B1 (fr) |
| CN (1) | CN105873618B (fr) |
| AU (1) | AU2014362497B2 (fr) |
| CA (1) | CA2930840C (fr) |
| ES (1) | ES2800524T3 (fr) |
| MX (1) | MX2016006991A (fr) |
| RU (1) | RU2667008C2 (fr) |
| SG (1) | SG11201604227XA (fr) |
| WO (1) | WO2015087839A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10098654B2 (en) * | 2016-03-28 | 2018-10-16 | Olympus Corporation | Arthroendoscopical surgical method |
| US10010338B2 (en) * | 2016-03-28 | 2018-07-03 | Olympus Corporation | Meniscectomy by arthroendoscopical surgical method |
| US20220062441A1 (en) * | 2019-01-07 | 2022-03-03 | The Brigham And Women`S Hospital, Inc. | Methods for imaging and treating damaged cartilage |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6627201A (en) * | 2000-05-03 | 2001-11-12 | Mbt Munich Biotechnology Gmbh | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| EP1330268A1 (fr) | 2000-10-11 | 2003-07-30 | Targesome, Inc. | Agents therapeutiques cibles |
| WO2002096367A2 (fr) * | 2001-05-30 | 2002-12-05 | Targesome, Inc. | Macromolecules polyvalentes cibles |
| KR101125678B1 (ko) * | 2004-02-06 | 2012-03-28 | 롬 앤드 하스 일렉트로닉 머트어리얼즈, 엘.엘.씨. | 개선된 이미지화 조성물 및 방법 |
| EP1738773A1 (fr) | 2005-06-29 | 2007-01-03 | Schering AG | Composition comprenant des particules d'oxide de fer et son utilisation en imagerie médicale |
| JP5463013B2 (ja) | 2007-06-19 | 2014-04-09 | 国立大学法人 岡山大学 | 軟骨マーカー |
| WO2009097704A1 (fr) * | 2008-02-05 | 2009-08-13 | Esbatech Ag | Polypeptides se liant à l'antigène pour lutter contre la dégénérescence du cartilage |
| RU2400146C1 (ru) * | 2009-06-02 | 2010-09-27 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" | Способ прогнозирования повреждения хряща на суставной поверхности надколенника у пациентов с феморо-пателлярной патологией коленного сустава |
| EP2826785B1 (fr) | 2012-03-13 | 2017-08-09 | National University Corporation Okayama University | Dérivé d'oligomère de lysine et marqueur de tissu cartilagineux fabriqué à partir de celui- ci |
-
2014
- 2014-12-08 SG SG11201604227XA patent/SG11201604227XA/en unknown
- 2014-12-08 JP JP2015552445A patent/JP6220894B2/ja active Active
- 2014-12-08 RU RU2016127950A patent/RU2667008C2/ru active
- 2014-12-08 MX MX2016006991A patent/MX2016006991A/es unknown
- 2014-12-08 US US15/039,123 patent/US10143762B2/en active Active
- 2014-12-08 AU AU2014362497A patent/AU2014362497B2/en active Active
- 2014-12-08 CN CN201480068338.9A patent/CN105873618B/zh active Active
- 2014-12-08 KR KR1020167013769A patent/KR101860117B1/ko active IP Right Grant
- 2014-12-08 ES ES14870461T patent/ES2800524T3/es active Active
- 2014-12-08 CA CA2930840A patent/CA2930840C/fr active Active
- 2014-12-08 EP EP14870461.2A patent/EP3081234B1/fr active Active
- 2014-12-08 WO PCT/JP2014/082441 patent/WO2015087839A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| JP6220894B2 (ja) | 2017-10-25 |
| RU2667008C2 (ru) | 2018-09-13 |
| CN105873618A (zh) | 2016-08-17 |
| EP3081234A1 (fr) | 2016-10-19 |
| CA2930840C (fr) | 2018-07-17 |
| WO2015087839A1 (fr) | 2015-06-18 |
| BR112016013652A2 (pt) | 2017-09-19 |
| ES2800524T3 (es) | 2020-12-30 |
| CA2930840A1 (fr) | 2015-06-18 |
| CN105873618B (zh) | 2019-07-26 |
| KR20160094943A (ko) | 2016-08-10 |
| EP3081234A4 (fr) | 2017-06-14 |
| EP3081234B1 (fr) | 2020-04-08 |
| US20170157271A1 (en) | 2017-06-08 |
| JPWO2015087839A1 (ja) | 2017-03-16 |
| AU2014362497A1 (en) | 2016-06-16 |
| US10143762B2 (en) | 2018-12-04 |
| MX2016006991A (es) | 2017-02-02 |
| KR101860117B1 (ko) | 2018-05-21 |
| AU2014362497B2 (en) | 2017-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219659A1 (zh) | 用於軟骨破壞的組合物 | |
| PL3065569T3 (pl) | Kompozycja | |
| EP2966153A4 (fr) | Composition d'huile lubrifiante | |
| EP2889350A4 (fr) | Composition collante-adhésive | |
| EP2964658A4 (fr) | Organofluoroborates substitués à titre d'agents d'imagerie | |
| HK1214088A1 (zh) | 油脂組合物 | |
| EP2966155A4 (fr) | Composition d'huile lubrifiante | |
| PT3027750T (pt) | Composição biocatalítica | |
| EP3006525A4 (fr) | Composition d'asphalte-uréthane | |
| HK1201482A1 (en) | Bone cement composition | |
| GB201318489D0 (en) | Composition | |
| EP2990028A4 (fr) | Composition épaississante | |
| GB201319540D0 (en) | Composition | |
| GB201317388D0 (en) | Composition | |
| GB201320919D0 (en) | Composition | |
| GB201306984D0 (en) | Composition | |
| EP3066178A4 (fr) | Composition lubrifiante | |
| GB201322772D0 (en) | Composition | |
| GB201320303D0 (en) | Composition | |
| GB201319538D0 (en) | Composition | |
| GB201317196D0 (en) | Composition | |
| GB201307622D0 (en) | Composition | |
| SG11201604227XA (en) | Articular cartilage imaging composition | |
| GB201420672D0 (en) | Composition | |
| GB201308502D0 (en) | Composition |